The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Comparison of Dynamic Susceptibility-weighted Contrast-enhanced MR Methods: Recommendations for Measuring Relative Cerebral Blood Volume in Brain Tumors
Open accessAbstract
PURPOSE: To investigate whether estimates of relative cerebral blood volume (rCBV) in brain tumors, obtained by using dynamic susceptibility-weighted contrast material-enhanced magnetic resonance (MR) imaging vary with choice of data acquisition and postprocessing methods. MATERIALS AND METHODS: Four acquisition methods were used to collect data in 22 high-grade glioma patients, with informed written consent under HIPAA-compliant guidelines approved by the institutional review board. During bolus administration of a standard single dose of gadolinium-based contrast agent (0.1 mmol per kilogram of body weight), one of three acquisition methods was used: gradient-echo (GRE) echo-planar imaging (echo time [TE], 30 msec; flip angle, 90 degrees ; n = 10), small-flip-angle GRE echo-planar imaging (TE, 54 msec; flip angle, 35 degrees ; n = 7), or dual-echo GRE spiral-out imaging (TE, 3.3 and 30 msec; flip angle, 72 degrees ; n = 5). Next, GRE echo-planar imaging (TE, 30 msec; flip angle, 90 degrees ; n = 22) was used to collect data during administration of a second dose of contrast agent (0.2 mmol/kg). Subsequently, six methods of analysis were used to calculate rCBV. Mean rCBV values from whole tumor, tumor hot spots, and contralateral brain were normalized to mean rCBV in normal-appearing white matter. RESULTS: Friedman two-way analysis of variance and Kruskal-Wallis one-way analysis of variance results indicated that qualitative rCBV values were dependent on acquisition and postprocessing methods for both tumor and contralateral brain. By using the nonparametric Mann-Whitney test, a consistently positive (greater than zero) tumor-contralateral brain rCBV ratio resulted when either the preload-postprocessing correction approach or dual-echo acquisition approach (P < .008 for both methods) was used. CONCLUSION: The dependence of tumor rCBV on the choice of acquisition and postprocessing methods is caused by their varying sensitivities to T1 and T2 and/or T2* leakage effects. The preload-correction approach and dual-echo acquisition approach are the most robust choices for the evaluation of brain tumors when the possibility of contrast agent extravasation exists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
AFNI: Software for analysis and visualization of functional magnetic resonance neuroimages
Cox, R. W. (1996) · Computers and Biomedical Research · doi:10.1006/cbmr.1996.0014 · Cited by 10,913
Batchelor, T. T., Sorensen, A. G., di Tomaso, E., Zhang, W.-T., Duda, D. G., Cohen, K. S., Kozak, K. R., Cahill, D. P., Chen, P.-J., Zhu, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.021 · Cited by 1,769
Histological Typing of Tumours of the Central Nervous System
Kleihues, P., Burger, P. C., & Scheithauer, B. W. (1993) · Springer eBooks · doi:10.1007/978-3-642-84988-6 · Cited by 1,532
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
Vredenburgh, J. J., Desjardins, A., Herndon, J. E., Marcello, J., Reardon, D. A., Quinn, J. A., Rich, J. N., Sathornsumetee, S., Gururangan, S., Sampson, J., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.2440 · Cited by 1,394
Perfusion imaging with NMR contrast agents
Rosen, B. R., Belliveau, J. W., Vevea, J. M., & Brady, T. J. (1990) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910140211 · Cited by 1,151
Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings.
Aronen, H. J., Gazit, I. E., Louis, D. N., Buchbinder, B. R., Pardo, F. S., Weisskoff, R. M., Harsh, G. R., Cosgrove, G. R., Halpern, E. F., & Hochberg, F. H. (1994) · Radiology · doi:10.1148/radiology.191.1.8134596 · Cited by 908
Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence
Norden, A. D., Young, G. S., Setayesh, K., Muzikansky, A., Klufas, R., Ross, G. L., Ciampa, A. S., Ebbeling, L. G., Levy, B., Drappatz, J., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000304121.57857.38 · Cited by 801
Boxerman, J. L., Schmainda, K. M., & Weisskoff, R. M. (2006) · PubMed · Cited by 686
Self-citationGlial Neoplasms: Dynamic Contrast-enhanced T2*-weighted MR Imaging
Knopp, E. A., Cha, S., Johnson, G., Mazumdar, A., Golfinos, J. G., Zagzag, D., Miller, D. C., Kelly, P. J., & Kricheff, I. I. (1999) · Radiology · doi:10.1148/radiology.211.3.r99jn46791 · Cited by 596
Functional cerebral imaging by susceptibility‐contrast NMR
Belliveau, J. W., Rosen, B. R., Kantor, H. L., Rzedzian, R. R., Kennedy, D. N., McKinstry, R. C., Vevea, J. M., Cohen, M. S., Pykett, I. L., & Brady, T. J. (1990) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910140311 · Cited by 570
Cha, S., Knopp, E. A., Johnson, G., Wetzel, S. G., Litt, A. W., & Zagzag, D. (2002) · Radiology · doi:10.1148/radiol.2231010594 · Cited by 525
Law, M., Yang, S., Babb, J. S., Knopp, E. A., Golfinos, J. G., Zagzag, D., & Johnson, G. (2004) · PubMed Central · Cited by 508
Microvessel density is a prognostic indicator for patients with astroglial brain tumors
Leon, S. P., Folkerth, R. D., & Black, P. M. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960115)77:2<362::aid-cncr20>3.0.co;2-z · Cited by 481
Donahue, K. M., Krouwer, H. G. J., Rand, S. D., Pathak, A. P., Marszalkowski, C. S., Censky, S. C., & Prost, R. W. (2000) · Magnetic Resonance in Medicine · doi:10.1002/1522-2594(200006)43:6<845::aid-mrm10>3.0.co;2-j · Cited by 253
Danchaivijitr, N., Waldman, A. D., Tozer, D. J., Benton, C. E., Brasil Caseiras, G., Tofts, P. S., Rees, J. H., & Jäger, H. R. (2008) · Radiology · doi:10.1148/radiol.2471062089 · Cited by 238
Schmainda, K. M., Rand, S. D., Joseph, A. M., Lund, R., Ward, B. D., Pathak, A. P., Ulmer, J. L., Baddrudoja, M. A., Baddrudoja, M. A., & Krouwer, H. G. J. (2004) · PubMed Central · Cited by 197
Self-citationBrain Tumor Imaging in Clinical Trials
Henson, J. W., Ulmer, S., & Harris, G. J. (2008) · American Journal of Neuroradiology · doi:10.3174/ajnr.a0963 · Cited by 167
Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging.
Maeda, M., Itoh, S., Kimura, H., Iwasaki, T., Hayashi, N., Yamamoto, K., Ishii, Y., & Kubota, T. (1993) · Radiology · doi:10.1148/radiology.189.1.8372199 · Cited by 167
Aronen, H. J., Pardo, F. S., Kennedy, D. N., Belliveau, J. W., Packard, S. D., Hsu, D. W., Hochberg, F., Fischman, A. J., & Rosen, B. R. (2000) · PubMed · Cited by 159
Measuring blood volume and vascular transfer constant from dynamic, T‐weighted contrast‐enhanced MRI
Johnson, G., Wetzel, S. G., Cha, S., Babb, J. S., & Tofts, P. S. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20049 · Cited by 145
Cha, S., Knopp, E., Johnson, G., Litt, A. W., Glass, J., Gruber, M. L., Lu, S., & Zagzag, D. (2000) · PubMed · Cited by 127
Perfusion MR Imaging of Brain Tumors
Cha, S. (2004) · Topics in Magnetic Resonance Imaging · doi:10.1097/00002142-200410000-00002 · Cited by 111
Signal‐to‐noise analysis of cerebral blood volume maps from dynamic NMR imaging studies
Boxerman, J. L., Rosen, B. R., & Weisskoff, R. M. (1997) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880070313 · Cited by 101
Siegal, T., Rubinstein, R., Tzuk-Shina, T., & Gomori, J. M. (1997) · Journal of neurosurgery · doi:10.3171/jns.1997.86.1.0022 · Cited by 91
Analysis of dynamic contrast enhanced MRI
Jackson, A. (2004) · British Journal of Radiology · doi:10.1259/bjr/16652509 · Cited by 85
Dual dynamic contrast‐enhanced MR imaging
Miyati, T., Banno, T., Mase, M., Kasai, H., Shundo, H., Imazawa, M., & Ohba, S. (1997) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880070136 · Cited by 69
Descriptive Analysis and Quantification of Angiogenesis in Human Brain Tumors
Folkerth, R. D. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1006499824379 · Cited by 59
Heiland, S., Benner, T., Debus, J., et al. (1999) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(98)00149-0 · Cited by 55
Expanding the Clinical Development of Bevacizumab
Chen, H. X. (2004) · The Oncologist · doi:10.1634/theoncologist.9-suppl_1-27 · Cited by 37
Cited by
Barajas, R. F., Chang, J. S., Segal, M. R., Parsa, A. T., McDermott, M. W., Berger, M. S., & Cha, S. (2009) · Radiology · doi:10.1148/radiol.2532090007 · Cited by 407
Hu, L. S., Baxter, L. C., Smith, K. A., Feuerstein, B. G., Karis, J. P., Eschbacher, J. M., Coons, S. W., Nakaji, P., Yeh, R. F., Debbins, J., et al. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1377 · Cited by 396
Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas
Dhermain, F. G., Hau, P., Lanfermann, H., Jacobs, A. H., & van den Bent, M. J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70181-2 · Cited by 368
Pseudoprogression of brain tumors
Thust, S. C., van den Bent, M. J., & Smits, M. (2018) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.26171 · Cited by 304
Gahramanov, S., Muldoon, L. L., Varallyay, C. G., Li, X., Kraemer, D. F., Fu, R., Hamilton, B. E., Rooney, W. D., & Neuwelt, E. A. (2013) · Radiology · doi:10.1148/radiol.12111472 · Cited by 162
Metadata
- Authors
- Paulson, E. S., & Schmainda, K. M.
- Venue
- Radiology
- Published
- 2008-11
- Volume
- 249
- Issue
- 2
- Pages
- 601-613
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2100481498
- Cited by
- 327
- References
- 30
- FWCI
- 13.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.